−0.0176USD
−3.03 MUSD
78.90 M
About Inhibitor Therapeutics Inc.
Sector
CEO
Frank E. O'Donnell
Headquarters
Tampa
Website
Employees (FY)
9
Founded
1992
FIGI
BBG000BW1RH7
Inhibitor Therapeutics, Inc. engages in the discovery, development, and commercialization of therapeutics for patients with cancer. It focuses on SUBA-Itraconazole, a patented, oral formulation of Itraconazole, for treatment of prostate and lung cancers. The company was founded on September 30, 1992 and is headquartered in Tampa, FL.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of INTI is 0.0858 USD — it has increased by 50.53% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Inhibitor Therapeutics Inc. stocks are traded under the ticker INTI.
Inhibitor Therapeutics Inc. is going to release the next earnings report on May 16, 2024. Keep track of upcoming events with our Earnings Calendar.
INTI stock is 33.57% volatile and has beta coefficient of 1.73. Check out the list of the most volatile stocks — is Inhibitor Therapeutics Inc. there?
Yes, you can track Inhibitor Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
INTI stock has risen by 25.26% compared to the previous week, the month change is a 22.57% rise, over the last year Inhibitor Therapeutics Inc. has showed a 186.00% increase.
INTI net income for the last quarter is −1.17 M USD, while the quarter before that showed −664.76 K USD of net income which accounts for −75.59% change. Track more Inhibitor Therapeutics Inc. financial stats to get the full picture.
Today Inhibitor Therapeutics Inc. has the market capitalization of 9.81 M, it has increased by 39.46% over the last week.
No, INTI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, INTI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Inhibitor Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 9.00 employees. See our rating of the largest employees — is Inhibitor Therapeutics Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Inhibitor Therapeutics Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Inhibitor Therapeutics Inc. stock shows the neutral signal. See more of Inhibitor Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.